Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib.
Inanc N, Abacar KY, Ozturk MA, Tufan A, Karadeniz H, Sari I, Can G, Erez Y, Pehlivan Y, Dalkilic HE, Ocak T, Cefle A, Yazici A, Senel AS, Akar S, Durak-Ediboğlu E, Koca SS, Piskin-Sagir R, Yilmaz S, Gulcemal S, Soysal-Gunduz O, Basibuyuk CS, Alkan S, Cesur TY, Onen F. Inanc N, et al. Among authors: koca ss. J Clin Rheumatol. 2023 Dec 1;29(8):365-369. doi: 10.1097/RHU.0000000000002026. Epub 2023 Sep 19. J Clin Rheumatol. 2023. PMID: 37724891 Free PMC article.
The IL-33 gene is related to increased susceptibility to systemic sclerosis.
Koca SS, Pehlivan Y, Kara M, Alibaz-Oner F, Oztuzcu S, Yilmaz N, Cetin GY, Kisacik B, Ozgen M, Pamuk ON, Direskeneli H, Sayarlioglu M, Onat AM. Koca SS, et al. Rheumatol Int. 2016 Apr;36(4):579-84. doi: 10.1007/s00296-015-3417-8. Epub 2016 Jan 7. Rheumatol Int. 2016. PMID: 26743213
Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort.
Kalyoncu U, Solmaz D, Emmungil H, Yazici A, Kasifoglu T, Kimyon G, Balkarli A, Bes C, Ozmen M, Alibaz-Oner F, Erten S, Cagatay Y, Cetin GY, Yilmaz S, Yildiz F, Pamuk ON, Kucuksahin O, Kilic L, Yazisiz V, Karadag O, Koca SS, Hayran M, Akar S, Aksu K, Akkoc N, Keser G, Gonullu E, Kisacik B, Onat AM, Soy M, Inanc N, Direskeneli H, Sayarlioglu M, Erken E, Turgay M, Cefle A, Ertenli I, Pay S. Kalyoncu U, et al. Among authors: koca ss. J Autoimmun. 2016 May;69:59-63. doi: 10.1016/j.jaut.2016.02.010. Epub 2016 Mar 9. J Autoimmun. 2016. PMID: 26970681
Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective data.
Kimyon G, Kalyoncu U, Kiraz S, Bes C, Coşkun N, Yağiz B, Küçükşahin O, Kanitez N, Erden A, Kiliç L, Bilgin E, Kaşifoğlu T, Emmungil H, Koca SS, Akar S, Çinar M, Yazisiz V, Ateş A, Ersözlü D, Gönüllü E, Mercan R, Ertenli İ. Kimyon G, et al. Among authors: koca ss. Clin Exp Rheumatol. 2021 Jul-Aug;39(4):852-858. doi: 10.55563/clinexprheumatol/jhpymv. Epub 2020 Sep 4. Clin Exp Rheumatol. 2021. PMID: 32896266
Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic.
Kalyoncu U, Pehlivan Y, Akar S, Kaşifoğlu T, Kimyon G, Karadağ Ö, Dalkılıç HE, Ertenli Aİ, Kılıç L, Ersözlü D, Bes C, Emmungil H, Mercan R, Ediboğlu ED, Kanıtez N, Bilgin E, Çolak S, Koca SS, Gönüllü E, Küçükşahin O, Coşkun N, Yağız B, Kiraz S. Kalyoncu U, et al. Among authors: koca ss. Turk J Med Sci. 2021 Aug 30;51(4):1615-1623. doi: 10.3906/sag-2012-5. Turk J Med Sci. 2021. PMID: 33611869 Free PMC article.
Uveitis-related Factors in Patients With Spondyloarthritis: TReasure Real-Life Results.
Yaşar Bilge NŞ, Kalyoncu U, Atagündüz P, Dalkılıç E, Pehlivan Y, Küçükşahin O, Bes C, Akar S, Cinar M, Emmungil H, Ersözlü D, Ateş A, Mercan R, Kimyon G, Koca SS, Gonullu E, Yazisiz V, Tekgöz E, Alpay-Kanitez N, Erden A, Kiraz S, Coskun BN, Yağız B, İlgen U, Karadağ Ö, Kilic L, Ertenli İ, Kasifoglu T. Yaşar Bilge NŞ, et al. Among authors: koca ss. Am J Ophthalmol. 2021 Aug;228:58-64. doi: 10.1016/j.ajo.2021.03.026. Epub 2021 Apr 4. Am J Ophthalmol. 2021. PMID: 33826929
117 results